{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-004154","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2026-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.280377+00:00","generated_at":"2026-05-16T06:31:30.858257+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Anebulo completes oversubscribed tender offer, buys 300K shares at $3.50/share","bullets":["Final count: 4,907,881 shares tendered, oversubscribed.","Accepted 300,000 shares (incl. 134,306 odd lots) at $3.50/share for ~$1.05M.","Proration factor 3.47392%; accepted shares = 0.73% of shares outstanding.","CEO: pleased to provide smaller stockholders opportunity to sell at premium to market."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-004154","json":"https://secwatch.observer/filing/0001493152-26-004154.json","markdown":"https://secwatch.observer/filing/0001493152-26-004154.md","text":"https://secwatch.observer/filing/0001493152-26-004154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000149315226004154/0001493152-26-004154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000149315226004154/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:31:30.858257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}